A GLP-1 tsunami is headed for the vice industry. Good.
A new wave of cheap weight-loss drugs heralds an existential crisis for the sin economy
Add BT as a preferred source
THERE is a new breed on the rise among us – they look just like your childhood friends and long-time colleagues, but they are no longer the people you used to know.
They are turning up to brunch in athleisure wear, picking at their food and refusing dessert.
Even as their waistlines shrink, the tribe of obesity or GLP-1 drug users is rapidly expanding. Since 2020, prescriptions for drugs such as Wegovy, Ozempic and Mounjaro have more than tripled in the US alone.
TRENDING NOW
Abandoned ‘Titanic’, failing ‘ancient towns’: Why China’s tourism boom leaves white elephants behind
‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse
SpaceX surge further boosts Saudi billionaire prince’s fortune
Singapore’s total employment growth slows in Q1; job vacancies dip while retrenchments inch up
